Pfizer, Flynn Pharma can appeal fines over epilepsy-drug pricing behaviors: UK CAT
MLex Summary: Pfizer and Flynn Pharma can appeal fines imposed by the Competition Appeal Tribunal over epilepsy-drug pricing behaviors, the CAT has ruled. The CAT's ruling to fine the companies, through...To view the full article, register now.
Already a subscriber? Click here to view full article